Browsing: Prostate

Top Line: Even among men with prostate cancer, cardiovascular disease–not cancer–remains the leading cause of death.The Study: This should remain…

Top Line: Does dose-escalation of prostate radiation still move the needle in the setting of long-course androgen deprivation therapy (ADT)?The…

Top Line: Hypofractionation of post-prostatectomy radiation has never really taken off due to concern of worse late side effects. The…

The VA’s uptake of guideline-concordant surveillance for favorable-risk prostate cancer is remarkable, with active surveillance/watchful waiting rising from 27% to…

A NCDB analysis reports 1.3% of men with localized prostate cancer treated at Commission on Cancer–accredited US centers from 2010–2023…

A single-institution retrospective cohort of 101 patients receiving ultra-hypofractionated radiation 36.25 Gy to the prostate and 25 Gy to pelvic…

Top Line: We learned at ASTRO that relatively lower-dose ultra-hypofractionated prostate radiation results in less bowel effects at the expense…

Top Line: Should Pluvicto be added to ADT and an androgen receptor pathway inhibitor for metastatic, castration sensitive prostate cancer?…

Top Line: Does an empty bladder increase urinary effects from prostate SBRT? The Study: Most people treat prostate cancer patients…